A multivariate genome-wide association study of psycho-cardiometabolic multimorbidity

Coronary artery disease (CAD), type 2 diabetes (T2D) and depression are among the leading causes of chronic morbidity and mortality worldwide. Epidemiological studies indicate a substantial degree of multimorbidity, which may be explained by shared genetic influences. However, research exploring the presence of pleiotropic variants and genes common to CAD, T2D and depression is lacking. The present study aimed to identify genetic variants with effects on cross-trait liability to psycho-cardiometabolic diseases. We used genomic structural equation modelling to perform a multivariate genome-wide association study of multimorbidity (Neffective = 562,507), using summary statistics from univariate genome-wide association studies for CAD, T2D and major depression. CAD was moderately genetically correlated with T2D (rg = 0.39, P = 2e-34) and weakly correlated with depression (rg = 0.13, P = 3e-6). Depression was weakly correlated with T2D (rg = 0.15, P = 4e-15). The latent multimorbidity factor explained the largest proportion of variance in T2D (45%), followed by CAD (35%) and depression (5%). We identified 11 independent SNPs associated with multimorbidity and 18 putative multimorbidity-associated genes. We observed enrichment in immune and inflammatory pathways. A greater polygenic risk score for multimorbidity in the UK Biobank (N = 306,734) was associated with the co-occurrence of CAD, T2D and depression (OR per standard deviation = 1.91, 95% CI = 1.74–2.10, relative to the healthy group), validating this latent multimorbidity factor. Mendelian randomization analyses suggested potentially causal effects of BMI, body fat percentage, LDL cholesterol, total cholesterol, fasting insulin, income, insomnia, and childhood maltreatment. These findings advance our understanding of multimorbidity suggesting common genetic pathways.

[1]  R. de Graaf,et al.  Depression, cardiometabolic disease, and their co-occurrence after childhood maltreatment: an individual participant data meta-analysis including over 200,000 participants , 2023, BMC Medicine.

[2]  A. Dehghan,et al.  Pleiotropic genetic architecture and novel loci for C-reactive protein levels , 2022, Nature Communications.

[3]  Z. Kutalik,et al.  Bias correction for inverse variance weighting Mendelian randomization , 2022, bioRxiv.

[4]  D. Easton,et al.  Applying Mendelian randomization to appraise causality in relationships between smoking, depression and inflammation , 2022, Scientific reports.

[5]  A. Auton,et al.  Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways , 2022, Nature Genetics.

[6]  Byoungjin Park,et al.  Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease , 2022, Biomedicines.

[7]  S. Djurovic,et al.  Shared genetic loci between depression and cardiometabolic traits , 2022, PLoS genetics.

[8]  M. Jarvelin,et al.  Genetic analysis of over half a million people characterises C-reactive protein loci , 2022, Nature Communications.

[9]  Jacob C. Ulirsch,et al.  Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants , 2021, Nature Genetics.

[10]  D. Melzer,et al.  188-LB: Type 2 Diabetes Is Genetically Correlated with Multiple Long-Term Conditions but These Correlations Are Only Partly Explained by BMI , 2021, Diabetes.

[11]  Zachary F. Gerring,et al.  Symptom-level modelling unravels the shared genetic architecture of anxiety and depression , 2021, Nature Human Behaviour.

[12]  B. Penninx,et al.  Dissecting Depression Biological and Clinical Heterogeneity-The Importance of Symptom Assessment Resolution. , 2021, JAMA psychiatry.

[13]  B. Penninx,et al.  Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts , 2021, Molecular Psychiatry.

[14]  D. Belsky,et al.  Investigating the genetic architecture of noncognitive skills using GWAS-by-subtraction , 2021, Nature Genetics.

[15]  G. Rojo-Martínez,et al.  Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients , 2020, Scientific Reports.

[16]  H. Aburatani,et al.  Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease , 2020, Nature Genetics.

[17]  Kyle J. Gaulton,et al.  Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation , 2020, Nature Genetics.

[18]  M. Paulus,et al.  Toll-Like Receptor Signaling in Depression , 2020, Psychoneuroendocrinology.

[19]  M. Hotopf,et al.  Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption , 2020, Psychological Medicine.

[20]  Fuquan Zhang,et al.  Multi-trait analysis for genome-wide association study of five psychiatric disorders , 2020, Translational Psychiatry.

[21]  Alexander E. Lopez,et al.  Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis , 2020, Nature Genetics.

[22]  William J. Astle,et al.  The Polygenic and Monogenic Basis of Blood Traits and Diseases , 2020, Cell.

[23]  A. Hewitt,et al.  Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration , 2020, European Journal of Epidemiology.

[24]  H. Sibaii,et al.  Toll-like receptors activation, signaling, and targeting: an overview , 2019 .

[25]  M. Munafo,et al.  Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study , 2019, Psychological Medicine.

[26]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[27]  Sebastian M. Armasu,et al.  Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes , 2019, Circulation. Genomic and precision medicine.

[28]  S. Lewis,et al.  Disentangling causal relationships between inflammatory markers and depression: a bidirectional Mendelian randomization analysis , 2019, bioRxiv.

[29]  Shing Wan Choi,et al.  PRSice-2: Polygenic Risk Score software for biobank-scale data , 2019, GigaScience.

[30]  S. Larsson,et al.  Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study , 2019, European heart journal.

[31]  N. Wray,et al.  Genetic comorbidity between major depression and cardio-metabolic disease, stratified by age at onset of major depression , 2019, bioRxiv.

[32]  S. Besnard,et al.  Cooperation of the vestibular and cerebellar networks in anxiety disorders and depression , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  V. Vacic,et al.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.

[34]  Peter B. Jones,et al.  Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort , 2019, bioRxiv.

[35]  Hunna J. Watson,et al.  Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders , 2019, bioRxiv.

[36]  Liang Cheng,et al.  Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study , 2018, Front. Genet..

[37]  Guixia Wang,et al.  Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus , 2018, Journal of diabetes research.

[38]  Stephen R. Williams,et al.  Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. , 2018, American journal of human genetics.

[39]  R. Marioni,et al.  Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions , 2018, Nature Neuroscience.

[40]  Anthony J. Payne,et al.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.

[41]  M. Roccia,et al.  Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based , 2018, Front. Immunol..

[42]  Melissa J. Green,et al.  The genetics of the mood disorder spectrum: genome-wide association analyses of over 185,000 cases and 439,000 controls , 2018, bioRxiv.

[43]  Luke R. Lloyd-Jones,et al.  Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes , 2018, Nature Communications.

[44]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[45]  S. Linnarsson,et al.  Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways , 2018, Nature Genetics.

[46]  Stuart J. Ritchie,et al.  Genomic SEM Provides Insights into the Multivariate Genetic Architecture of Complex Traits , 2019, Nature Human Behaviour.

[47]  J. Vink,et al.  Causal associations between body mass index and mental health: a Mendelian randomisation study , 2018, Journal of Epidemiology & Community Health.

[48]  R. Marioni,et al.  Edinburgh Research Explorer Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways , 2022 .

[49]  Evangelos Evangelou,et al.  Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses , 2018, PloS one.

[50]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[51]  Changwei Li,et al.  Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis , 2018, Diabetes Care.

[52]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[53]  Anne Newman,et al.  Bivariate Genome-Wide Association Study of Depressive Symptoms With Type 2 Diabetes and Quantitative Glycemic Traits , 2017, Psychosomatic medicine.

[54]  N. Wray,et al.  Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations , 2017, JAMA psychiatry.

[55]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[56]  Kathryn S. Burch,et al.  Leveraging polygenic functional enrichment to improve GWAS power , 2017, bioRxiv.

[57]  N. Chatterjee,et al.  Heritability informed power optimization (HIPO) leads to enhanced detection of genetic associations across multiple traits , 2017, bioRxiv.

[58]  R. Hajar Risk Factors for Coronary Artery Disease: Historical Perspectives , 2017, Heart views : the official journal of the Gulf Heart Association.

[59]  Kristin G Ardlie,et al.  Genetic Analysis in UK Biobank Links Insulin Resistance and Transendothelial Migration Pathways to Coronary Artery Disease , 2017, Nature Genetics.

[60]  Giovanni Malerba,et al.  Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes , 2017, Nature Genetics.

[61]  Tanya M. Teslovich,et al.  An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans , 2017, Diabetes.

[62]  D. Lawlor,et al.  Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults , 2017, bioRxiv.

[63]  B. Horne,et al.  The association of depression at any time to the risk of death following coronary artery disease diagnosis , 2017, European heart journal. Quality of care & clinical outcomes.

[64]  Markus Perola,et al.  Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors. , 2017, American journal of human genetics.

[65]  A. Amare,et al.  The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies , 2017, Translational Psychiatry.

[66]  Blair H. Smith,et al.  Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort , 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[67]  D. Hinds,et al.  Identification of 15 genetic loci associated with risk of major depression in individuals of European descent , 2016, Nature Genetics.

[68]  A. Dehghan,et al.  Polygenic dissection of major depression clinical heterogeneity , 2016, Molecular Psychiatry.

[69]  J. Licinio,et al.  Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries , 2016, Molecular Psychiatry.

[70]  T. Laursen,et al.  Mortality and life expectancy in persons with severe unipolar depression. , 2016, Journal of affective disorders.

[71]  William Wheeler,et al.  A Powerful Procedure for Pathway-Based Meta-analysis Using Summary Statistics Identifies 43 Pathways Associated with Type II Diabetes in European Populations , 2016, bioRxiv.

[72]  B. Saltin,et al.  Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases , 2015, Scandinavian journal of medicine & science in sports.

[73]  Nobhojit Roy,et al.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition , 2015, The Lancet.

[74]  Ryan Miller,et al.  WikiPathways: capturing the full diversity of pathway knowledge , 2015, Nucleic Acids Res..

[75]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[76]  C. Dickens Depression in People with Coronary Heart Disease: Prognostic Significance and Mechanisms , 2015, Current Cardiology Reports.

[77]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[78]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[79]  B. Staels,et al.  Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? , 2015, Trends in Endocrinology & Metabolism.

[80]  Y. Gan,et al.  Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies , 2014, BMC Psychiatry.

[81]  S. Lerakis,et al.  Inflammation in Coronary Artery Disease , 2014, Cardiology in review.

[82]  B. Nordestgaard,et al.  Elevated C-Reactive Protein, Depression, Somatic Diseases, and All-Cause Mortality: A Mendelian Randomization Study , 2014, Biological Psychiatry.

[83]  E. Rimm,et al.  Fried-food consumption and risk of type 2 diabetes and coronary artery disease: a prospective study in 2 cohorts of US women and men. , 2014, The American journal of clinical nutrition.

[84]  F. S. Bersani,et al.  The role of cerebellum in unipolar and bipolar depression: a review of the main neurobiological findings. , 2014, Rivista di psichiatria.

[85]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[86]  D. McLoughlin,et al.  Epigenetics and depression: return of the repressed. , 2014, Journal of affective disorders.

[87]  Rui Mei,et al.  Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing , 2013, Molecular Psychiatry.

[88]  P. Sienaert,et al.  Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables , 2013, Psychological Medicine.

[89]  S. Djurovic,et al.  Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia , 2013, Molecular Psychiatry.

[90]  Antonio Cuadrado,et al.  Nrf2 participates in depressive disorders through an anti-inflammatory mechanism , 2013, Psychoneuroendocrinology.

[91]  Christian Gieger,et al.  The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis , 2013, BDJ.

[92]  E. Mannucci,et al.  Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. , 2013, The Journal of clinical psychiatry.

[93]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[94]  Paul Scheet,et al.  A Genome-Wide Association Scan on the Levels of Markers of Inflammation in Sardinians Reveals Associations That Underpin Its Complex Regulation , 2012, PLoS genetics.

[95]  Manuel A. R. Ferreira,et al.  Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits , 2011, BMC Medical Genetics.

[96]  J. de Irala,et al.  Fast-food and commercial baked goods consumption and the risk of depression , 2011, Public Health Nutrition.

[97]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[98]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[99]  Wei Wang,et al.  Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation , 2010, PLoS genetics.

[100]  B. Leonard,et al.  Association of high-sensitivity C-reactive protein with de novo major depression , 2010, British Journal of Psychiatry.

[101]  B. Leonard The concept of depression as a dysfunction of the immune system. , 2010, Current immunology reviews.

[102]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[103]  Kenneth S Kendler,et al.  Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. , 2009, Archives of general psychiatry.

[104]  Sherita Hill Golden,et al.  Depression and Type 2 Diabetes Over the Lifespan , 2008, Diabetes Care.

[105]  Stafford L. Lightman,et al.  The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.

[106]  Jackie A Cooper,et al.  Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream , 2008, PLoS medicine.

[107]  H. Kuper,et al.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. , 2006, European heart journal.

[108]  Satwat Hashmi,et al.  Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease , 2006, Coronary artery disease.

[109]  JoAnn E Manson,et al.  Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. , 2005, Journal of applied physiology.

[110]  Hong Xian,et al.  A Twin Study of Depression Symptoms, Hypertension, and Heart Disease in Middle‐Aged Men , 2003, Psychosomatic medicine.

[111]  W. Strawbridge,et al.  Prospective association between obesity and depression: evidence from the Alameda County Study , 2003, International Journal of Obesity.

[112]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[113]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[114]  P. Björntorp,et al.  The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke , 2000, Journal of internal medicine.

[115]  C. Le Page,et al.  Interferon activation and innate immunity. , 2000, Reviews in immunogenetics.